Image Source : ET HealthWorld
Piramal Pharma Ltd has received board approval to sell its decommissioned manufacturing unit located at A159, MIDC, Wagle Industrial Estate, Thane. The facility, which contributed zero revenue in the last financial year, will be sold to Sankalpan Architects for Rs 85 million.
Key Highlights:
-
The unit includes a plot of land and factory premises
-
Sale has no operational impact as the unit was nonfunctional
-
Buyer is unrelated to the promoter group, ensuring transparency
-
Transaction does not qualify as a related party deal
Execution Timeline:
-
A Memorandum of Understanding has been signed
-
Completion expected within six months, subject to definitive agreements
Strategic Context:
The sale aligns with Piramal Pharma’s ongoing efforts to streamline its asset base and focus on core operations. With no contribution to turnover or net worth, the divestment is seen as a prudent move to unlock idle capital.
Source: Moneyworks4me
Advertisement
Advertisement